Leptin and risk factors for atherosclerosis: A review

Cheng Wang,Liping Chang,Jia Wang,Libo Xia,Liyuan Cao,Wei Wang,Jianwen Xu,Huize Gao
DOI: https://doi.org/10.1097/md.0000000000036076
IF: 1.6
2023-11-29
Medicine
Abstract:Leptin is a hormone discovered in 1994. It is mainly secreted by adipocytes. [ 1 ] Leptin can bind to leptin receptor and cross the blood–brain barrier to act on the hypothalamus. It can inhibit appetite and control food intake. [ 2 ] In recent years, with the increase of leptin research, it has been found that abnormal leptin levels in the human body also have an important impact on diabetes, obesity, inflammation and other aspects. [ 3 , 4 ] However, obesity, hypertension, inflammatory reaction and other risk factors are common causes of atherosclerosis (AS). [ 5 , 6 ] AS is thought to be the result of a variety of factors characterized by thickening and stiffening of the arterial wall, narrowing of the vessel lumen, and localized fibrous tissue proliferation, lipid accumulation, and calcium deposits.AS is an important cause of coronary heart disease, cerebral infarction and other diseases, which seriously affects the health of patients. At the same time, it also brings huge economic burden to patients. The exact pathogenesis of AS is not well understood, but the risk factors that can lead to its emergence and progression have been investigated for many years. Leptin, as a pleiotropic cytokine, may be closely related to several common risk factors of AS. Therefore, it is of great significance to explore the relationship between leptin abnormalities and as risk factors. This review collates and summarizes the latest research results and related literature of leptin on risk factors of AS, to facilitate the exploration of the relationship between leptin and AS.
medicine, general & internal
What problem does this paper attempt to address?